[1]
C. Smith, “Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study”, Afr J Thoracic Crit Care Med, vol. 28, no. 4, pp. 172–180, Dec. 2022, doi: 10.7196/AJTCCM.2022.v28i4.220.